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Globin radicalThere is a relationship between cerebral vasculature andmultiple sclerosis (MS) lesions: abnormal accumulations
of iron have been found in the walls of dilated veins in MS plaques. The sources of this iron can be varied, but
capillary and venous hemorrhages leading to blood extravasation have been recorded, and could result in the
release of hemoglobin extracellularly. Extracellular hemoglobin oxidizes quickly and is known to become a
reactive molecule that triggers low-density lipoprotein oxidation and plays a pivotal role in atherogenesis.
In MS, it could lead to local oxidative stress, inﬂammation, and tissue damage. Here, we investigated whether
extracellular hemoglobin and its breakdown products can cause direct oxidative damage to myelin components
in a peroxidative environment such as occurs in inﬂamed tissue. Oxidation of lipidswas assessed by the formation
of ﬂuorescent peroxidized lipid–protein covalent adducts, by the increase in conjugated diene and
malondialdehyde. Oxidation of proteins was analyzed by the change in protein mass. The results suggest
that the globin radical could be a trigger of myelin basic protein oxidative cross-linking, and that heme
transferred to the lipids is involved in lipid peroxidation. This study provides new insight into the mechanism
bywhich hemoglobin exerts its pathological oxidative activity towards myelin components. This work supports
further research into the vascular pathology in MS, to gain insight into the origin and role of iron deposits in
disease pathogenesis, or in stimulation of different comorbidities such as cardiovascular disease.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Multiple sclerosis (MS) has been studied for more than 150 years,
but this devastating disease remains frustratingly enigmatic and has
been compared with the mythological Daedalus' labyrinth that has
not yet been conquered [1]. The inﬂammatory face of MS, together
with use of anti-inﬂammatory drugs to relieve the associated symp-
toms, strongly reﬂects the autoimmune nature of the disease. This
hypothesis invokes the idea of an “outside-in”mechanism of disease,
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iversity of Calgary, Calgary,demyelination and subsequent damage to neuropil [2]. However,
other recent studies have provided histopathological evidence that
MS may also be considered a degenerative disorder rather than solely
an autoimmune disease, and the concept of an “inside-out” model
of disease progression has arisen [3]. This model suggests that
the autoimmune and/or inﬂammatory responses are the secondary
reaction to the primary process that causes death of oligodendrocytes
and demyelination of axons in the central nervous system (CNS) [4,5].
Since Charcot's ﬁrst histological characterization ofmultiple sclerosis
[6], a relationship has been observed between cerebral vasculature
and MS lesions [7–9]. An abnormal iron accumulation has been shown
histologically and biochemically in MS [7,8,10,11] and, particularly, has
been found in the walls of the dilated veins in cerebral MS plaques
[12]. Studies of MS patients show evidence of iron accumulation in
grey matter structures such as the thalamus, globus pallidus, red nucle-
us, substantia nigra, putamen, caudate nucleus, and hippocampus, that
go beyond any age-related effects [13–16]. The brains of patients with
MS show iron staining inmacrophages andmicroglia, around sites of in-
ﬂammation, and near demyelinated plaques in gray and white matter
[17]. In general, the extent of iron accumulation in gray matter struc-
tures and lesions has been shown to be a good predictor of disability
progression in MS, as well as the extent of lesion accumulation and
level of cell death [17–20]. Moreover, it has been observed that iron-
deﬁcient mice fail to develop EAE, demonstrating that iron deﬁciency
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preventing EAE [21]. The deleterious effects of abnormal iron accu-
mulations on MS metabolism have been recently reviewed [15,20,
22].
The origin of the elevated iron deposits in MS is unknown, but they
are not necessarily simply a consequence of release from glial intracel-
lular ferritin stores [23] or inﬂammation [14,15]. In general, the most
abundant source of iron in the human body is heme, and iron released
from it plays a central role in multiple pathologies, such as reperfusion
after ischemia, trauma, and hemolysis. The major source of heme is
hemoglobin, the major protein in erythrocytes. Thus, any type of
cerebrospinal blood vessel abnormality [24] or abnormally permeable
blood–brain barrier [25,26] can potentially lead to intravascular
hemolysis, or to extravasation of erythrocytes and extravascular
hemolysis [27,28]. This situation resembles several pathologies that
are completely different from MS: atherosclerotic lesion formation
(intravascular hemolysis), chronic venous disorders, and chronic
hemorrhagic micro-stroke (intra- or extravascular hemolysis), all
resulting in the release of hemoglobin extracellularly [29]. Under
these conditions, as a result of hemolysis, hemoglobin will appear
in its ferrous (Fe2+) form that can readily be oxidized to the ferric
(Fe3+) or ferryl (Fe4+) forms [30–32]. Due to its nature, oxidized
extracellular hemoglobin is a highly-reactive molecule. This reactivity
is operative in numerous pathologies, and could be derived from three
major properties: the oxidative activity of intact hemoglobin (and/or
its chains); the oxidative activity of heme released from hemoglobin
(and/or its chains); and the oxidative reactivity of free iron released
from heme.
Each or all three of these pathways can be involved also in MS path-
ogenesis. For instance, intact hemoglobin can act as a peroxidase under
oxidative stress or inﬂammatory conditions [33]. Also, heme can be re-
leased from oxidized hemoglobin and, being a hydrophobic molecule,
can readily enter the hydrophobic domains of biological membranes
[34]. Thus, free heme can enter the myelin sheath and cause oxidative
damage directly to the constituent lipids and proteins [35]. Those
oxidatively-damaged proteins could initiate a secondary autoimmune
response. Lastly, heme is not a stable molecule, and deteriorates or
can be enzymatically oxidized to produce biliverdin, ferrous iron
(Fe2+), and carbon monoxide (CO). Under this last scenario, free iron
can give rise to oxidative stress and generation of free radicals [36].
Although mechanistically these three ways of hemoglobin-induced
damage are different, the outcome could be the same, namely local
oxidative stress, inﬂammation, and tissue damage. Thus, considering
the fact that the hemoglobin extravasation is a minor but chronic pro-
cess, over a certain period of time the disease can progress to its clinical
stagewhen severe demyelination and inﬂammation become noticeable.
Myelin, with its high proportion of polyunsaturated lipids, is an es-
pecially susceptible target for hemoglobin-induced oxidative attack
[37]. Disruption of lipid homeostasis can affect the integrity of myelin,
and promote neurodegeneration [38–40]. Oxidized lipoproteins can
be a source of pro-inﬂammatory and pro-atherogenic effects, induce ox-
idative stress, and cause neuronal degeneration [41]. Lipid peroxidation
products can also lead to proteinmodiﬁcation [18]. Myelin basic protein
(MBP), a highly positively-charged (pI N 10.5) peripheral protein of the
myelin sheath, has a crucial role in the formation and maintenance
of the myelin sheath [42]. Oxidized cholesterol has been shown to
increase the exposure of MBP to the cytoplasm, enhancing its suscepti-
bility to proteolytic cleavage [43]. The MBP is also a major candidate
auto-antigen in MS, and the increased exposure of immunodominant
epitopes of MBPmay allow recognition by the immune system [43–46].
The primary objective of this study was to investigate whether
hemoglobin can be considered as a player in the ensemble of different
factors that together damage myelin protein and lipids, and lead to
the progression of MS. An intact molecule of oxyHb was incubated
with lipid and protein components of myelin, and its direct oxidative
potential was assessed. Also, hydrogen peroxide was used in the lowmicromolar range (10 μM) to mimic oxidative stress as occurs under
inﬂammatory conditions [47–49]. Our results clearly indicate that Hb
causes oxidative stress/damage to cultured oligodendrocytes, and to
MBP andmyelin lipids in vitro, and that themechanism of this oxidative
damage could involve the formation of a globin radical and heme
transfer. Therefore, we conclude that extracellular hemoglobin can
play an important role in the pathogenesis of MS.
2. Materials and methods
2.1. Puriﬁcation of unmodiﬁed 18.5-kDa recombinant murine myelin basic
protein isoform (MBP) and oxyhemoglobin (oxyHb)
An unmodiﬁed 18.5-kDa recombinant murine MBP isoform (MBP,
168 residues), without any tags or other recombinant additions, was
expressed in Escherichia coliBL21-CodonPlus(DE3)-RP cells (Stratagene,
La Jolla, CA) and puriﬁed by ion exchange chromatography as previously
described [50]. Pure fractions were collected and their purity was
conﬁrmed by SDS-PAGE (sodium dodecyl sulfate-polyacrylamide
gel electrophoresis), then extensively dialyzed (6000–8000 Da dialysis
tubing) against 2 × 2 L of Buffer A (50 mM Tris-base, 250 mM NaCl,
pH 7.4), 2 × 2 L of Buffer B (100 mM NaCl), and 4 × 2 L MilliQ water.
Following dialysis, the puriﬁed samples were lyophilized until dry
and then stored at−20 °C. Before use, the frozen MBP stock was re-
suspended inMilliQwater. Protein concentrationwas determined by
measuring the absorbance at 280 nm, using the extinction coefﬁcient
ε= 0.705 L g−1 cm−1 (as calculated by SwissProt for protein in 6.0 M
guanidine hydrochloride, 0.02 M phosphate buffer, pH 6.5).
Hemoglobin was purchased from Sigma-Aldrich (Oakville, Canada).
Contaminants (mainly catalase) were removed by CM-52 ion exchange
chromatography as previously described [51], and spectrophotometri-
cally veriﬁed to be a mixture of oxyHb and metHb. MetHb was pro-
duced by the addition of 10% molar excess of potassium ferricyanide
followed by extensive dialysis against water [52], aliquoted, and frozen
at−80 °C. OxyHb was prepared from the metHb stock by gel ﬁltration
on a G25 column (25 × 1.5 cm) and fast protein liquid chromatography
(FPLC) at 4 °C [53]. Brieﬂy, 0.2 mL of 0.1 g/mL of sodium dithionite was
added to the column at 1 mL/min, followed by 1 mL of ~18 mMmetHb
when all of the sodium dithionite had completely entered the gel bed.
The product, deoxy-ferrous hemoglobin, was visible as a purple band
at the top of the column, and changed its color to red (oxyHb) while
moving through the column. The concentration of oxyHb was deter-
mined using the absorbance at wavelengths 541, 577, and 415 nm
with extinction coefﬁcients of 13.8, 14.6, and 125 cm−1 mM−1,
respectively [52]. Concentrations of Hb are expressed in heme
equivalents throughout this study. OxyHbwas analyzed for potential
contamination with endotoxin using an Endosafe®-PTS Reader
equipped with the Endosafe®-PTS cartridge-0.05 EU/mL sensitivity
(Charles River Laboratories, Sherbrooke, QC). Using this method, we
determined that the concentration of endotoxin under experimental
conditions was ≤3.47 ng/mL.
2.2. Formation of cytoplasmic large unilamellar lipid vesicles (cytLUVs)
All lipids (cholesterol, phosphatidylinositol (PI), phosphatidyl-
choline (PC), phosphatidylserine (PS), phosphatidylethanolamine
(PE), sphingomyelin (SM)) were purchased from Avanti Polar Lipids
(Alabaster, AL) and stored at−20 °C until use. Aliquots of chloroform
solutions of cholesterol, PE, PS, PC, SM, and PI were combined in a
44:27:13:11:3:2 mole ratio, which is characteristic of the cytoplasmic
leaﬂet of myelin [54]. Lipids (in chloroform) were combined in a glass
tube, and solvent was evaporated under a steady stream of nitrogen
gas, followed by an over-night lyophilization. The lipid ﬁlm was resus-
pended in 5mLof double-distilledwater to yield an ~20mMconcentra-
tion, and layered under argon gas. Vesicles were subjected to three
freeze (−20 °C) and thaw (1 h at 45–50 °C) cycles with occasional
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aliquots. To prepare unilamellar vesicles, frozen samples were thawed
and extruded (at 45 °C) to ensure size homogeneity of vesicles with a
100-nm diameter. After extrusion, lipids were stored at 4 °C until use.
The Modiﬁed Micro-Bartlett Phosphorus Assay was used to determine
the molar concentration of the lipid vesicles [55].
2.3. Cell line culture
TheN19 immortalized oligodendroglial cell line [56,57]was grown as
previously described [58] in DMEM high-glucose media supplemented
with 10% FBS (fetal bovine serum) and 1% penicillin/streptomycin,
and cultured in 10-cm plates at 34 °C/5% CO2. At 70–80% conﬂuency
(4–7 days), cells were detached using 0.25% trypsin for 5 min, and
were seeded onto 2-cm plates containing a glass coverslip at a density
of 0.5 × 106 cells/mL.
2.4. Oxidation experiments
All reactions were carried out at 37 °C in phosphate-buffered saline
(PBS), pH 7.4 (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM
KH2PO4) under air. Preparations of cytLUVs (0.6 mg/mL = 1 mM) or
MBP (100 μg/mL = 54 μM), or both, were incubated for up to 25 h
with oxyHb (10 μM) in the presence or absence of an equimolar concen-
tration (10 μM) of H2O2. Samples from the reaction mixture were taken
at different time-points (0, 0.5, 1, 2, 3, 4, 5, 9, and 25 h) for analysis of the
oxidation products.
Protein oxidation products (MBP and globin)were analyzed by SDS-
PAGE (5% stacking, 14% separating) [59] or Tricine-PAGE (4% stacking,
16.5% separating) [60] under reducing conditions. At each time-point,
a 15-μL sample from the reaction mixture was mixed with 2× Sample
Buffer (100 mM Tris–HCl, pH 6.8, 24% v/v glycerol, 1% w/v SDS, 2% v/v
β-mercaptoethanol, 0.02% Coomassie G-250), boiled, and loaded onto
the gel. To prove the presence of MBP in the higher molecular mass
bands observed on the gels, proteinswere transferred to a nitrocellulose
membrane. After transfer, membranes were incubated with 2% gelatin
for 1 h, then washed 5 × 5 min in 0.5% (v/v) Tween-20 in Tris-
buffered saline (TBS and TTBS, respectively). Membranes were then in-
cubated with 1° antibody (E5) rabbit anti-MBP (generous gift from Dr.
J.M. Boggs, Research Institute, Hospital for Sick Children, Toronto, ON)
with dilution 1:1000 in 1% gelatin for 1 h. Membranes were washed
again 5 × 5 min in TTBS, and incubated with 2° antibody goat anti-
rabbit rat IgG horse-radish peroxidase (HRP) conjugate GAR-MRP
(Sigma A9169), with dilution 1:80,000 in TTBS, for 45 min. Membranes
were then washed 5 × 5 min in TTBS, and then developed using the
ECL Western Blotting Detection Kit (GE Healthcare Life Sciences,
Baie d'Urfe, QC). Membranes were imaged using the Molecular Imager
ChemiDoc XRS system (Bio-Rad Laboratories, Mississauga, ON).
Oxidation of cytLUVs was determined in terms of the formation of
thiobarbituric acid reactive substances (TBARS) [61], of the develop-
ment of conjugated diene or triene, by absorbance at 234 and/or
268 nm, respectively [62], and of the development of ﬂuorescent
lipid–protein conjugates [63]. For the TBARS assay, at each time-point,
a 100-μL sample from the reaction mixture was mixed with 200 μL
water and 600 μL of TBA reagent (0.375% w/v TBA, 0.25 N HCl, 15% v/v
trichloroacetic acid), then boiled for 15 min, and spun at 21,500 ×g for
2 min. The supernatant absorbance was measured at 532 nm and an
extinction coefﬁcient of 1.56 × 105 cm−1 M−1 was used to quantify
MDA equivalents in different samples [64]. The evolution of absorbance
at 268 nm in the reactionmixtures wasmonitored by collecting UV–Vis
spectra (220–700 nm) at different time points using a micro-plate
reader equipped with a thermostat (Polarstar Omega, BMG Laboratory
Technologies, Offenburg, Germany). The change in ﬂuorescence
intensity due to the formation of protein–lipid covalent adducts
was monitored by collecting emission spectra (365–600 nm) at
different time points following excitation at 360 nm [65].2.5. Quantiﬁcation of hemoglobin oxidation states
The absorbance spectrum (220–700 nm) of the reaction mixtures
was taken at different time-points using a micro-plate reader
equipped with a thermostat (Polarstar Omega, BMG Laboratory
Technologies, Offenburg, Germany), and the absorbance at 700 nm
wasused as the baseline. From those spectra, three discretewavelengths
(560, 577, 630nm)were derived for further analysis. The concentrations
of the three hemoglobin species (in μM) were calculated using
multicomponent analysis from the following equations for reactions
starting from oxyHb:
oxyHb½  ¼ −1:44A560 þ 68:42A577− 82:17A630 ð1Þ
metHb½  ¼ −79:25A560 þ 41:83A577 þ 318:08A630 ð2Þ
ferrylHb½  ¼ 95:97A560− 54:49A577−46:88A630 ð3Þ
aspreviouslydescribed [66]. Additionally, thepresenceof ferrylhemoglobin
at the same time points was conﬁrmed by its reaction with Na2S [67].
Brieﬂy, 20 mM Na2S was added to the samples withdrawn from the
reaction mixtures at different time points to reach the ﬁnal concentra-
tion of 2 mM. The absorbance spectrum (350–700 nm) was taken and
the concentration of sulfhemoglobin was calculated using the extinc-
tion coefﬁcient ε620 nm = 24 mM−1 cm−1 [67]. The contribution of
ferrylHb to the absorbance at 560, 577, and 630 nm of the reaction
mixtures (not supplemented with Na2S) at different time points was
subtracted using the previously published extinction coefﬁcients of
ferrylHb at those speciﬁc wavelengths [66,68]. The concentrations
of metHb and oxyHb (in μM) were calculated using multicomponent
analysis from the following equations:
oxyHb½  ¼ 66A577− 80A630 ð4Þ
metHb½  ¼ − 3A577 þ 279A630 ð5Þ
as previously described [66].
2.6. Destruction of heme during the course of oxidation
Samples of 17 μL were withdrawn from the reaction mixtures
at different time points and mixed with 153 μL of concentrated
formic acid. The absorbance was measured at 398 nm and the
concentration of hemin was calculated using the extinction coefﬁ-
cient ε398 nm = 153 mM−1 cm−1 [69].
2.6. Tryptophan ﬂuorescence and heme transfer to cytLUV
Changes in tryptophan ﬂuorescence during the auto-oxidation of
oxyHb or in the reaction mixtures with MBP or cytLUVs were followed
using excitation at 280 nmor 295 nm, and emission at 335 nm. Fluores-
cence intensitymeasured at different time points (F.I.t = i) was present-
ed as a ratio of the maximal intensity recorded after 24 h of incubation
(F.I.t = 24 h).
To test the heme transfer from Hb to the lipid phase, ﬂuorescent
cytLUVs were made by introducing the marker 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-(5-dimethylamino-1-
naphthalenesulfonyl) at 0.1% or 1% molar ratio and decreasing the
molar ratio of PE to 26.9% or 26%, respectively. The emission spectra
(with the maximum at 531 nm) were monitored at different time
points over the course of reaction following excitation at 360 nm.
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3.1. Effect of hemoglobin on cultured, immortalized oligodendrocytes
ExtracellularHb is susceptible to auto-oxidation and,when oxidized,
is an extremely reactive protein. Its highly hydrophobic heme moiety
can dissociate from the oxidized Hb and invade cell membranes,
where it triggers oxidative modiﬁcations of lipids, and induces cell
stress and even death, as well as damage of cellular proteins. Here,
immortalized N19 oligodendrocyte cells were plated at a density of
0.5 × 106 cells/mL. Then, 10 μM oxyHb was added and cells were
further incubated at 37 °C. At different time intervals, cell integrity
was followedmicroscopically. The oxyHb-treated cells clearly exhibited
signs of stress as seen by retraction of membrane process extensions
(Fig. 1). After 6 h, cells demonstrated nearly complete membrane
collapse, which only worsened over the 24-hour time-course. Under
these conditions, cellular lipids and proteins, including MBP, could
become vulnerable for further direct oxidative damage by Hb, and so
we examined this scenario in vitro in the present study.
3.2. Oxidative state of hemoglobin upon interaction with myelin lipids
and MBP
Extracellular Hb can exert its oxidative potential via several different
mechanisms, but the common denominator is a change in the heme
moiety of the protein. Therefore, ﬁrst we examined how the heme
group of Hb changes upon interaction with myelin lipids and MBP.
To mimic the myelin sheath, we prepared large unilamellar vesicles
(cytLUVs) with the lipid composition that represents the cytoplasmic
leaﬂet of the oligodendrocyte membrane [54]. Each oxidative state of
Hb is characterized by typical absorbance peaks, which can be used for
quantiﬁcation at different time-points of the reaction. The challenging
part, though, is to distinguish the ferryl state (Fe4+) from hemichrome,
since their spectral characteristics are similar and both can be generated
during the course of Hb oxidation [66].Fig. 1. A time-course experiment of immortalized N19 oligodendrocyte cells following trea
supplemented with 10% FBS and 1% penicillin/streptomycin, and cultured in 2 cm plates
micrographs depict signs of stress as seen by retractions of membrane process extensions
and reduced adhesion to the plate, which did not recover over the 24-hour time-course. BIn this set of experiments, oxyHb was incubated separately with
cytLUVs, MBP, or by itself in the absence (data not shown) or presence
of H2O2 to mimic oxidative stress during inﬂammatory processes.
Representative spectral changes that happened over the course of the
reaction time are shown in Fig. 2 (panels A, C, E). In all reaction
mixtures, we observed a fast decrease in the absorbance at 415, 541
and 577 nm (suggestive of disappearance of oxyHb), and an increase
at 630 nm (indicative of metHb formation). These spectral changes
(all marked by arrows in Fig. 2) are suggestive of the conversion of
oxyHb undoubtedly to metHb, but also to ferrylHb and/or hemichrome
[66].We analyzed these changes bymulticomponent analyses using the
equations that describe the simultaneous presence of oxyHb/metHb/
hemichrome [66] or of oxyHb/metHb/ferrylHb (Eqs. (1)–(3)). Both
analyses showed comparable rates and amounts of oxyHb disappear-
ance and metHb formation, but they failed to distinguish between
ferrylHb and hemichrome (data not shown).
To distinguish between the latter two states at each time point,
a sample from the reaction mixtures was reacted with Na2S that
reacts exclusively with the ferryl state and results in the formation of
sulfhemoglobin with a new distinctive absorbance peak at 620 nm
[67,70]. The representative results of this experiment are shown
in the insets to the main Fig. 2 (panels A, C, E, see also Fig. S1 in the
Supplementary Material), and clearly indicate that the ferryl state was
present in all reaction mixtures. From these results, we calculated the
concentration of ferrylHb at each time point in all reaction mixtures,
and its contribution to the absorbance at 560, 577, and 630 nm was
subtracted. Following this manipulation, spectra were reanalyzed for
the simultaneous presence of either oxyHb/metHb (Eqs. (4), (5)) or
oxyHb/metHb/hemichrome [66]. The representative results of this
analysis are shown in Fig. 2 (panels B, D, F), and indicate that certainly
oxyHb was diminished over the course of reaction, while ferrylHb and
metHb were formed.
Regarding the presence of hemichrome, themulticomponent analysis
allowed us to detect it only at later time points (after 3 h of incubation),
and its concentrationwas less than 1 μΜ (data not shown). Therefore, thetment with 10 μM Hb (ferrous form). Cells were grown in DMEM high-glucose media
at 34 °C/5% CO2 at a density of 0.5 × 106 cells/mL. Differential interference contrast
(white arrows). Following 6 h, cells demonstrate nearly complete membrane collapse
ar = 50 μm.
Fig. 2.Change in oxidative states of heme iron over time in reactionmixtures containing equimolar (10 μM) amounts of oxyHb and hydrogen peroxide (A, B); in the presence of 100 μg/mL
MBP (C, D); or in the presence of 0.6 mg/mL cytLUVs (E, F). Reactionmixtures were incubated at 37 °C in PBS (pH 7.4), and spectrawere collected at different time points. Representative
spectral changes (A, C, E) are shown at time zero (solid), 30 min (dash), 60 min (dot), 120 min (dash dot), 180 min (dash dot dot), and 23 h (short dash). The region of 450–700 nm is
magniﬁed and plotted vs. the right y-axis scale. The insets show the presence of ferrylHb, measured at time zero and after 30 min, by reacting an aliquot from the reaction mixtures with
Na2S (the rest of the time points are shown in Figure S1 in the SupplementaryMaterial). The amounts of different heme species (B, D, F) were calculated by subtracting the contribution of
ferryl hemoglobin from the absorbance readings at 560, 577, and 630 nm, and applying Eqs. (4) and (5) (seeMaterials andmethods for details). Data presented are a representative result
of three independent measurements.
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is suggestive of the total denaturation of Hb and dissociation of the
heme moiety from the protein. By closer examination and comparison
of different reaction mixtures, we observed that when oxyHb was
mixed with cytLUVs in the absence of H2O2 (data not shown), oxyHb
was oxidized to the same level as in the mixture of oxyHb/H2O2, thus in-
dicating the involvement of lipid peroxides. The addition of H2O2 to the
mixture of oxyHb/cytLUVs signiﬁcantly increased the susceptibility of
Hb to oxidative denaturation and to the loss of heme (Fig. 2E and F).However, the overall level of met- and ferrylHb formation stayed
the same.
Another important observation is that under all conditions, ferrylHb
formation reached its maximum at ~40–50 min and then slowly
decreased, probably by converting into metHb and/or denatured Hb.
This observation indicates that the ferryl state was possibly directly
involved in the lipid or protein oxidation, and suggests that the oxida-
tive activity of Hb towards myelin components could operate via a
ferryl-dependent mechanism (as a classical peroxidase, such as HRP).
97V.V. Bamm et al. / Biochimica et Biophysica Acta 1852 (2015) 92–1033.3. Liberation of heme and its transfer to cytLUVs
In the previous section, we showed that part of the absorbance loss
at 415 nm could be explained by the conversion of oxyHb to met- and
ferrylHb, and probably later to denatured hemichrome. However, the
drop in the total amount of Hb in the reaction mixtures suggests that
a signiﬁcant amount of heme was destroyed and/or liberated from
globin over the course of incubation. First, we followed the destruction
of heme in the same reaction mixtures presented in Fig. 2 using the
formic acid assay. The representative results are shown in Fig. 3A and
B and they clearly indicate that, indeed, heme was destroyed over the
course of the incubation. An important observation was that heme
destruction was much faster in the mixtures containing cytLUVs, thus
indicating the participation of the lipid peroxides and potentially a
transfer of the heme moiety to the lipid bilayer (to which point we
return below). The most pronounced heme destruction after 24 h of
reaction was observed in the presence of cytLUVs and in the mixture
containingMBP/H2O2, where the total heme loss was ~40–45% (Fig. 3B).
When heme is bound to globin, the tryptophan ﬂuorescence in Hb is
quenched by resonance energy transfer [71]. Therefore, an increase in
tryptophan ﬂuorescence reports on heme dissociation from the globin
and/or its destruction. Indeed, globin tryptophanﬂuorescence increased
upon auto-oxidation of oxyHb, and the rate of increase wasmuch faster
in the mixture with cytLUVs, as shown in Fig. 3C. After 24 h of incuba-
tion, the ﬂuorescence intensity reached ~350% of the initial level inFig. 3. Destruction of heme and change in globin ﬂuorescence. Total heme concentration was
presented in Fig. 2 with concentrated formic acid andmeasuring the absorbance at 398 nm (A, B
ﬂuorescence (excitation 295 nm/emission 335nm). The emissionwas normalized to the highes
and lowest intensities (D). Representative experiment is shown for kinetic experiments (A, C)the mixture of oxyHb/H2O2, and an even higher level (~450%) in the
presence of cytLUVs (Fig. 3D). Whereas the presence of hydrogen
peroxide resulted in a signiﬁcant increase of tryptophan ﬂuorescence
during the auto-oxidation of oxyHb, it did not affect the emission in
the mixture with cytLUVs. Surprisingly, we did not observe any pro-
nounced change in tryptophan ﬂuorescence in the mixtures containing
MBP. We attribute this result to the masking effect of the single trypto-
phan in the 18.5-kDa MBP sequence that was the main source of ﬂuo-
rescence in the mixtures containing this protein.
Finally, we examined whether the dissociation and destruction of
heme in the mixtures containing cytLUVs were accompanied by its
transfer to the lipid vesicles. For this experiment, we used ﬂuorescently
labeled cytLUVs (dansylated) and followed signal quenching over the
course of incubation (Fig. 4A). The results of this experiment conﬁrmed
heme transfer to cytLUVs, which in the beginning appeared to be
slightly faster in the presence of H2O2. After a one-hour incubation, the
signal quenching became more pronounced in the absence of hydrogen
peroxide, probably due to slower heme deterioration (Fig. 3A).
3.4. Myelin lipids and protein oxidation induced by Hb
Next, using the same reaction mixtures described above, we
examined the ability of Hb to trigger lipid and protein oxidative
modiﬁcations. Oxidation of the myelin lipids was followed by three
parameters: (i) formation of ﬂuorescent peroxidized lipid–proteindetected at different time points by reacting an aliquot from the same reaction mixtures
). Liberation of heme from globinwasmonitored kinetically (C) bymeasuring tryptophan
t intensity detected after 24 h of incubation (C), or presented as a ratio between the highest
and mean ± S.D. (n = 3) for the end-point measurement after 24 h of incubation (B, D).
Fig. 4. Heme transfer and lipid oxidation. The emission at 531 nm (excitation 360 nm) was followed in the reaction mixtures containing 10 μM oxyHb and 0.6 mg/mL cytLUVs
(ﬂuorescently-labeled) in the presence or absence of 10 μM H2O2 incubated at 37 °C in PBS buffer (pH 7.4) (A). In the same reaction mixtures, lipid oxidation was also monitored. An
increase in ﬂuorescence intensity at 435 nm (excitation 360 nm) indicative of oxidized lipid–protein covalent adducts (B), absorbance at 268 nm indicative of formation of conjugated
dienes and/or trienes (C), and TBARS expressed in MDA equivalents (D), were measured. Measurements were taken at different time points (A, B), or for the starting time-point and
the end point (C, D). Representative result is shown for kinetic experiments (A, B) and mean ± S.D. (n = 3) for the end-point measurement after 24 h of incubation (C, D).
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(iii) the amount of TBARS developed over the course of the reaction
(Fig. 4B–D). While measuring heme transfer from Hb to cytLUVs,Fig. 5. Proteinmobility on Tricine-polyacrylamide gels. Samples from the reactionmixtures tha
panel contained oxyHb (10 μM) alone or a mixture of oxyHb (10 μM)/cytLUVs (0.6mg/mL), bo
(100 μg/mL) or oxyHb (10 μM) alone, or a mixture of MBP (100 μg/mL)/oxyHb (10 μM) in the p
measurements. The letters (“m”), (“d”), and (“o”) in the left-hand panel gel indicate monomerwe also noticed the development of a new emission peak at 435 nm
(Fig. 4B). This peak previously was reported to be a result of a covalent
bonding between peroxidized lipids and protein primary amines via thet were incubated at 37 °C in PBS (pH 7.4) were taken at 0 and 24 h. The gel in the left-hand
th in the presence or absence of H2O2 (10 μM); the right-hand panel contained either MBP
resence or absence of H2O2 (10 μM). Data are presented as a representative result of three
s, dimers, and oligomers, respectively.
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ﬂuorescent products was much faster in the presence of hydrogen
peroxide. It is also important to mention that since the lipids that we
used to prepare the cytLUVs were characterized by a relatively low
presence of unsaturated bonds, a low level of lipid oxidation products
was to be expected. Indeed, after 25 h of reaction time, the absorbance
at 268 nm increased only by ~0.4 absorbance units (a.u.), both in the
presence and absence of H2O2. At the same time, the amount of MDA
equivalents doubled compared to the controls. Even though the
presence of H2O2 increased the rate of peroxidation (data not shown),
it did not affect the total amount of the products observed after 25 h
of incubation (Fig. 4C and D), since the maximal level of peroxidation
was reached within this time frame.
Simultaneously, we followed the formation of protein oxidation
products in the same reaction mixtures using Tricine-PAGE (Fig. 5).
We observed, as expected, a covalent globin–globin cross-linking
upon interaction with H2O2 [72]. These higher molecular mass cross-
linked products, and the reduction in the intensity of the bands corre-
sponding to monomeric globin, became even more evident in the
presence of myelin lipids, and the lack of H2O2 in the reaction did not
inﬂuence their amount (Fig. 5). This observation is in agreement with
our ﬁnding above that, even in the absence of H2O2, myelin lipids
promoted the formation of the ferryl state (data not shown) and further
degradation of the heme prosthetic group (Fig. 3A). More importantly,
in the reaction mixtures where MBP was present, we observed the
formation of the higher molecular mass bands too, but those were
muchweaker, and the addition of external peroxide did not signiﬁcant-
ly increase their intensity or amount. Also, the amount of monomeric
globin did not seem to change signiﬁcantly. This result suggests that
MBP somehow inhibited cross-linking of globin to itself, probably by
taking the oxidative potential of Hb on itself and reducing or terminat-
ing the globin radical. Again, this result correlates with our previous
observation that in the presence of MBP, the ferryl-state heme moiety
was more prominent, and the amount of total Hb remained higher
than in the reactions where MBP was not included (Fig. 2C and D).
In the next set of experiments, we tried to mimic the process that
could take place in the CNS under inﬂammatory conditions, namely,
we mixed MBP with cytLUVs to imitate the natural myelin milieu, and
then applied Hb and H2O2. Under these experimental conditions, MBP
interacts with lipids, mostly due to its electrostatic properties, and
forms semi-solid lipid–protein aggregates [73]. Therefore, to analyze
the products of Hb-induced oxidation, we measured protein and lipidFig. 6. Changes in heme moiety and lipid oxidation upon interaction of oxyHb with reconstitu
the reaction mixture): cytLUVs (0.6 mg/mL) + oxyHb (10 μM) + MBP (100 μg/mL) + H2O2
(whole mixture, supernatant (S.N.), and pellet from the same reaction mixture used in (A)). Doxidative modiﬁcations in the whole reaction mixture, and also
separately in the soluble and insoluble fractions.
Firstly, the analysis of the supernatant or soluble part of the reaction
mixture (Fig. 6A) showed that the changes in the oxidative state of Hb
resembled those observed over the course of Hb interaction with
cytLUVs in the presence of hydrogen peroxide (Fig. 2F), but with a
more pronounced tendency towards heme deterioration. At the same
time, MBP was not detected in the supernatant, and the amount of
oxidized lipids (judged by MDA equivalents) reached the same level
as in the reaction with cytLUVs (compare Figs. 4D and 6B). Only a
small portion of those oxidatively-modiﬁed lipids was detected in the
aggregates. Also, a small yet detectable amount of heme was found in
the aggregated material (data not shown), thus providing further evi-
dence for intercalation of heme within the hydrophobic environment
of the lipid–protein aggregates.
Secondly, using polyacrylamide gel electrophoresis (Fig. 7A), we
observed the formation of higher molecular mass bands of low intensi-
ty, similar to those detected in the reaction of Hb with MBP in the
presence of hydrogen peroxide (Fig. 5, right panel). Concomitantly,
there was no pronounced change in the amounts of the monomeric
forms of globin or MBP during the ﬁrst 5 h of the reaction, followed by
a decrease in the intensity of their monomeric bands after 24 h.
To understand the nature of those higher molecular mass products,
we performed Western blotting with an MBP-speciﬁc antibody
(Fig. 7B). Clearly, even after just 30 min of incubation, MBP was
detectable in the higher molecular mass bands. The intensity of
those bands reached saturation approximately between 1 and 2 h
of the reaction time, with the formation of even higher molecular
mass complexes after 24 h. Finally, in the absence of lipids (Fig. 7C),
only the minor presence of MBP was detected in those weak, higher
molecular mass bands observed on the gel presented in Fig. 5, thus
indicating an important role of lipids in inﬂuencing Hb-induced
oxidative damage to MBP.
4. Discussion
4.1. Potential relevance to the pathogenesis of multiple sclerosis
For the purpose of this study, we assumed that the scenario
described in Fig. 8 and recently reviewed [27,28] could be involved in
the pathogenesis of MS. According to this model, local iron overload
occurs already in the very early stages of disease in nascent MS lesions,ted myelin. (A) Change in oxidative states of heme iron over time (in the supernatant of
(10 μM) at 37 °C in PBS, pH 7.4. (B) Formation of TBARS expressed as MDA equivalents
ata are presented as a mean ± S.D. (n = 3).
Fig. 7. Oxidative cross-linking of proteins. Reaction mixture of MBP (100 μg/mL), oxyHb
(10 μM), cytLUVs (0.6 mg/mL) and hydrogen peroxide (10 μM) was incubated in PBS
buffer (pH 7.4). At different time-points, the products of oxidation were sampled by
Tricine-polyacrylamide gel electrophoresis (A) with subsequent Western blot analysis
(B) with anti-MBP antibody. (C) Western blot analysis of the oxidation products in the
reaction mixture of MBP (100 μg/mL) and oxyHb (10 μM) in the presence (left lane) or
absence (right lane) of H2O2 following 24 h incubation at 37 °C. The letters (“m”), (“d”),
and (“o”) indicate monomer, dimer, and oligomer, respectively. Note that the globin
band is invisible in panels (B) and (C), and the nature of the higher molecular
mass bands could be either heteromeric (MBP–globin cross-linking) or homomeric
(MBP–MBP cross-linking).
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autoimmune attack [13,17,74]. Several studies support this idea
that localized iron overload can contribute both to the initial as
well as ongoing pathogenesis of the disease. First, an iron-deﬁcient
diet is more efﬁcient than pharmaceutical compounds in inhibiting
EAE [21]. Second, susceptibility-weighted MRI is a powerful method
of analyzing iron and vasculature in MS lesions [13,17,19,74,75].
It has recently demonstrated an abnormal iron accumulation in
adolescent MS [76] and clinically-isolated syndrome [77], and partic-
ularly the presence of deoxyhemoglobin per se in lesions in an EAE
mouse model [78]. Capillary and venous hemorrhages leading to
blood extravasation have been previously recorded, and could result
in release of extracellular hemoglobin (Hb) that potentially may be a
source of iron deposits [7–9,11,79,80]. Hemoglobin is a major iron-
containing protein, and we posit here that its long-term release
and degradation may be a potential source for the iron accumulation
and neurodegeneration seen in MS (cf. [27,28,81]).
4.2. Mechanistic aspects of the damage inﬂicted by extracellular Hb to the
myelin components
Given the above considerations, this study investigated the ability
of extracellular Hb to induce oxidative damage to lipids and proteins
of the myelin sheath, and provides evidence for a new, potential role
of hemoglobin in demyelinating diseases such as multiple sclerosis.
Our data showed that hemoglobin was able to induce lipid and protein
oxidativemodiﬁcations, particularly in the conditions that imitated CNS
myelin (concomitant presence ofmyelin lipids andMBP). It is important
to note that Hb itself was also affected by the oxidative environment,
and its heme moiety changed to a higher oxidative state, namely,
the ferric (Fe3+) and ferryl (Fe4+) forms. Also, a product of auto-
oxidation was detected using polyacrylamide gel electrophoresis
and appeared in the form of a globin dimer or oligomer, as has been
previously described in the literature [30,61,82].Extracellular oxyHb (Fe2+), the oxygen carrying form of hemoglobin,
can undergo auto-oxidation to metHb (Fe3+) [83]. Reactions with
nitric oxide and hydrogen peroxide can accelerate the oxidation of
Hb, and allow for the formation of higher oxidation states of hemoglobin,
including ferrylHb (Fe4+), and a short-lived globin-associated radical
[83]. OxyHb can react with peroxides to form ferrylHb, as shown in
Eq. (6). FerrylHb is a powerful oxidizing agent, and is able to promote
peroxidation of fatty acids and oxidation of a variety of molecules
[84,85]. On the other hand, comproportionation occurs between
ferrylHb and oxyHb molecules, leading to the formation of metHb
[84] as in Eq. (7):
Hb Fe2þ
 
O2 þ H2O2 þ 2Hþ→Hb Fe4þ
 
þ O2 þ 2H2O ð6Þ
Hb Fe4þ
 
þ Hb Fe2þ
 
O2→2Hb Fe
3þ  þ O2: ð7Þ
Globin radicals can be formed by the interaction of metHb with
peroxides, to form ferryl-state iron (Fe4+) and a radical, as shown
in Eq. (8) [61]:
Globin–heme Fe3þ
 
þ H2O2 þ 2Hþ→ •Globin–heme Fe4þ
 
þ 2H2O: ð8Þ
In H2O2-oxidized Hb, this radical was deﬁned as a tyrosine- and/or
tryptophan-centered globin radical [84,86,87]. The globin radical is
short-lived and can terminate in auto-oxidation as a globin–globin
dimer. The results of our study indicate that the yield of this product is
low (Fig. 5), mostly due to an insufﬁcient amount of H2O2 (equimolar
to Hb). Furthermore, the amount of cross-linked globin signiﬁcantly
increased in the presence of lipids, therefore suggesting the involve-
ment and synergistic effect of lipid peroxides. On the other hand, the
globin radical can abstract an electron from a substrate (represented
as RH), forming a free radical species (R•), as shown in Eq. (9):
•Globin–heme Fe4þ
 
þ 2RHþ 2OH−→ Globin–heme Fe3þ
 
þ 2R•þ 2H2O: ð9Þ
The free radical chain reaction can then terminate with the interac-
tion of two identical free radical species to yield a homodimer, as
shown in Eq. (10):
2R • → R2: ð10Þ
Another option is the termination of the free radical with a globin
radical. The product of this reaction will be a cross-linked heterodimer
between the free radical species and globin.
The globin radical and ferrylHb have well-documented abilities to
induce lipid peroxidation, and are involved in the damage observed in
crush injury (rhabdomyelitis) in the kidney, subarachnoid hemorrhage,
and blood transfusion [88]. In the case of lipid, removal of an electron
from an unsaturated fatty acid by a globin radical to form a lipid radical
would catalyze extensive lipid peroxidation. The lipid radical can take
up oxygen to form the peroxyl radical, and interact with other lipid
radicals to terminate the free radical chain, or attack other membrane
proteins, thereby spreading the damage.
However, ferrylHb and the globin-radical are not the only molecules
that trigger lipid peroxidation. In general, the afﬁnity between globin
and heme dramatically decreases upon auto-oxidation. Under these
conditions, heme could be transferred to another hydrophobic entity
such as a lipid bilayer (cell membrane) or lipid vesicles (the cytLUVs
in our experimental set-up). There, it can release free iron and catalyze
lipid peroxidation [34,51,89–91]. The result of lipid peroxidation is
altered membrane structure, function, and signaling [92]. The results
of our study indisputably showed that Hb induced oxidative modiﬁca-
tions in the myelin lipids, at least partially resulting from heme transfer
to the lipid vesicle (Fig. 4A). As a result of lipid oxidation, we detected
Fig. 8. Schematic presentation of the potential series of events leading to hemoglobin's pathological role in MS. Hemoglobin extravasation is a minor but chronic process, and over a
protracted period of time the disease can progress to its clinical stage when severe demyelination and inﬂammation become noticeable. It is important to remember that we need to
consider this abnormality not as a cause of disease, but only as a risk factor amongst many, and search for other factors that in combination will result in development of MS. In this
case, it is suggested that dysfunction in mechanisms involved in protection from extracellular hemoglobin-induced damage can be another risk factor that shifts the balance towards
disease. Legend: BBB — blood–brain barrier; RBC — red blood cell.
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formation, and an increase in TBARS (Fig. 4B–D). Also, an increase in the
yield of globin dimer in the presence of lipids (Fig. 5) suggests the in-
volvement of lipid peroxides as an additional product of lipid oxidation.
For MBP, oxidation may occur through the oxidation of amino acids
onMBP and formation of tyrosine radicals. Two such radicals can termi-
nate with each other to yield a homodimer, or with a globin radical that
would result in the formation of a heterodimer. Alternatively, the MBP
radical can terminatewith a lipid radical to result in a protein–lipid con-
jugate, though this product is not expected to exhibit a signiﬁcant
change in its running pattern on the SDS-PAGE due to minimal change
in the molecular mass. The mechanism of protein oxidative cross-
linking by termination of tyrosine radicals is similar to hemoglobin's
role in oxidation of low-density lipoprotein (LDL) as one of the possible
mechanisms leading to atherosclerosis. The pro-oxidizing environment
of atherosclerotic plaques leads to erythrocyte lysis, release of hemoglo-
bin, and oxidation to metHb and ferrylHb [35]. Hemoglobin induces
oxidation of low-density lipoprotein, partly through cross-linked ApoB protein [51,61,62,93]. Similar to the mechanism described above,
hemoglobin can function through a globin radical to initiate an Apo B
protein radical that terminates in intermolecular cross-linking, resulting
in LDL aggregation and phagocytosis by macrophages, thus ultimately
playing a crucial role in the process of atherogenesis [61].
In the case of MBP, a consequence of the formation of its higher
molecular mass components is that these dimers/oligomers have the
potential to be recognized by the immune system as foreign epitopes,
trigger immune system activation and inﬂammation, and initiate an
autoimmune response. While this is a novel hypothesis for MS, in the
case of atherosclerosis, aggregation of the oxidatively modiﬁed LDL
is an event that triggers autoimmune response and exacerbates in-
ﬂammation and formation of the atherosclerotic plaque [94,95].
The presence of hemoglobin or its breakdown products further exacer-
bates the inﬂammatory response [94,96]. In fact, heme can activate the
innate immune system through toll-like receptor 4, which is present on
microglia and other innate immune cells [97]. Iron, released from
hemoglobin, can act as a chemoattractant for immune cells, and can
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molecules that enhance transmigration of lymphocytes [15]. Iron can
also stimulate the release of certain proteinases that degrade the cells
surrounding the vascular system, thereby promoting adhesion and
migration of immune cells into the surrounding tissue, which become
activated and can then release pro-inﬂammatory molecules [15].
Therefore, a more comprehensive understanding of the potential role
and mechanism of Hb-induced oxidative modiﬁcation of the myelin
components will be essential for conquering the “labyrinth” of MS and
potentially will open new avenues for medical intervention.
5. Concluding remarks
In summary, our results show that hemoglobin is able to induce
oxidative damage to myelin lipid components and to MBP. Data from
this study, supported by the roles that hemoglobin plays in other
pathological conditions, suggest that hemoglobin is more than an inert
carrier of iron: hemoglobin represents another source of pathology
and should not be overlooked. The vascular role of extracellular
hemoglobin may explain the shared risk factor between MS and
other vascular diseases that prevail in MS patients. In particular,
MS patients have an increased risk of vascular diseases (including
myocardial infarction, deep venous thrombosis, and pulmonary
embolism) after the ﬁrst years of MS diagnosis [98]. Unfortunately,
it is not clear yet whether MS by itself presents a risk factor for
other vascular disorders, or if they share risk factors and are actually
comorbid. It can also be suggested that abnormalities in cranial
vascular hydrodynamics, sometimes but not exclusively observed
in MS patients [14], or an abnormal permeability of the blood–
brain barrier [25,26] may represent an additional risk factor for
development of the disease in the ﬁrst place. Future research into
the vascular pathology in MS will lend new insight into the role of iron
deposits in MS, the potential of hemoglobin as a source of iron overload,
and the role of subclinical blood extravasation in MS pathogenesis.
Acknowledgements
We thankDr. JoanM. Boggs (Hospital for Sick Children, Toronto, ON)
for her generous gift of 1° antibody (E5) rabbit alpha-MBP. We are
grateful to Drs. Christopher Hall and Michael Marit (Environmental
Biology, Guelph, ON) for performing the endotoxin analysis. This work
was supported by the Natural Sciences and Engineering Research
Council of Canada (Discovery Grant RG121541 to GH) and by a private
charitable donation in support of this work. ELS was the recipient of
an endMS Summer Research Assistantship. GSTS was the recipient of a
Doctoral Studentship from the Multiple Sclerosis Society of Canada.
GH is a Tier 1 Canada Research Chair in Myelin Biology.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2014.10.009.
References
[1] A. Achiron, The multiple sclerosis labyrinth—Poirot's solution, Autoimmun. Rev. 5
(2006) 509–510.
[2] J.J. Geurts, P.K. Stys, A. Minagar, S. Amor, R. Zivadinov, Gray matter pathology in
(chronic) MS: modern views on an early observation, J. Neurol. Sci. 282 (2009)
12–20.
[3] A.P. Henderson, M.H. Barnett, J.D. Parratt, J.W. Prineas, Multiple sclerosis:
distribution of inﬂammatory cells in newly forming lesions, Ann. Neurol. 66
(2009) 739–753.
[4] S. Tsutsui, P.K. Stys, Degeneration versus autoimmunity in multiple sclerosis, Ann.
Neurol. 66 (2009) 711–713.
[5] P.K. Stys, Multiple sclerosis: autoimmune disease or autoimmune reaction? Can. J.
Neurol. Sci. 37 (Suppl. 2) (2010) S16–S23.
[6] J. Charcot, Histologie de la sclerose en plaques, Gazette Des Hopitaux Paris 41 (1868)
554–555.[7] C.W. Adams, R.N. Poston, S.J. Buk, Y.S. Sidhu, H. Vipond, Inﬂammatory vasculitis in
multiple sclerosis, J. Neurol. Sci. 69 (1985) 269–283.
[8] C.W. Adams, Perivascular iron deposition and other vascular damage in multiple
sclerosis, J. Neurol. Neurosurg. Psychiatry 51 (1988) 260–265.
[9] M. Law, A.M. Saindane, Y. Ge, J.S. Babb, G. Johnson, L.J. Mannon, J. Herbert, R.I.
Grossman, Microvascular abnormality in relapsing-remitting multiple sclerosis:
perfusion MR imaging ﬁndings in normal-appearing white matter, Radiology 231
(2004) 645–652.
[10] J.C. Walton, J.C. Kaufmann, Iron deposits and multiple sclerosis, Arch. Pathol. Lab.
Med. 108 (1984) 755–756.
[11] W. Craelius, M.W. Migdal, C.P. Luessenhop, A. Sugar, I. Mihalakis, Iron deposits
surroundingmultiple sclerosis plaques, Arch. Pathol. Lab.Med. 106 (1982) 397–399.
[12] P. Zamboni, The big idea: iron-dependent inﬂammation in venous disease and
proposed parallels in multiple sclerosis, J. R. Soc. Med. 99 (2006) 589–593.
[13] E.M. Haacke, J. Garbern, Y. Miao, C. Habib, M. Liu, Iron stores and cerebral veins in
MS studied by susceptibility weighted imaging, Int. Angiol. 29 (2010) 149–157.
[14] R. Zivadinov, A. Lopez-Soriano, B. Weinstock-Guttman, C.V. Schirda, C.R. Magnano,
K. Dolic, C.L. Kennedy, C.L. Brooks, J.A. Reuther, K. Hunt, M. Andrews, M.G. Dwyer,
D.W. Hojnacki, Use of MR venography for characterization of the extracranial
venous system in patients with multiple sclerosis and healthy control subjects,
Radiology 258 (2011) 562–570.
[15] R. Williams, C.L. Buchheit, N.E. Berman, S.M. LeVine, Pathogenic implications of iron
accumulation in multiple sclerosis, J. Neurochem. 120 (2012) 7–25.
[16] K.J.Weigel, S.G. Lynch, S.M. Levine, Iron chelation andmultiple sclerosis, ASN Neurol
6 (2014) e00136.
[17] C.A. Habib, M. Liu, N. Bawany, J. Garbern, I. Krumbein, H.J. Mentzel, J. Reichenbach, C.
Magnano, R. Zivadinov, E.M. Haacke, Assessing abnormal iron content in the deep
gray matter of patients with multiple sclerosis versus healthy controls, AJNR Am. J.
Neuroradiol. 33 (2012) 252–258.
[18] H. Gonzalo, L. Brieva, F. Tatzber, M. Jove, D. Cacabelos, A. Cassanye, L. Lanau-Angulo, J.
Boada, J.C. Serrano, C. Gonzalez, L. Hernandez, S. Peralta, R. Pamplona,M. Portero-Otin,
Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a
potential pathogenic mechanism, J. Neurochem. 123 (2012) 622–634.
[19] M. Neema, A. Arora, B.C. Healy, Z.D. Guss, S.D. Brass, Y. Duan, G.J. Buckle, B.I. Glanz, L.
Stazzone, S.J. Khoury, H.L. Weiner, C.R. Guttmann, R. Bakshi, Deep gray matter
involvement on brain MRI scans is associated with clinical progression in multiple
sclerosis, J. Neuroimaging 19 (2009) 3–8.
[20] S. Hametner, I. Wimmer, L. Haider, S. Pfeifenbring, W. Bruck, H. Lassmann, Iron and
neurodegeneration in the multiple sclerosis brain, Ann. Neurol. 74 (2013) 848–861.
[21] S.M. Grant, J.A. Wiesinger, J.L. Beard, M.T. Cantorna, Iron-deﬁcient mice fail to
develop autoimmune encephalomyelitis, J. Nutr. 133 (2003) 2635–2638.
[22] E. Stephenson, N. Nathoo, Y. Mahjoub, J.F. Dunn, V.W. Yong, Iron in multiple sclerosis:
roles in neurodegeneration and repair, Nat. Rev. Neurol. 10 (2014) 459–468.
[23] H. Lassmann, J. van Horssen, The molecular basis of neurodegeneration in multiple
sclerosis, FEBS Lett. 585 (2011) 3715–3723.
[24] A.V. Singh, P. Zamboni, Anomalous venous blood ﬂow and iron deposition in
multiple sclerosis, J. Cereb. Blood Flow Metab. 29 (2009) 1867–1878.
[25] M. Schwartz, J. Kipnis, S. Rivest, A. Prat, How do immune cells support and shape the
brain in health, disease, and aging? J. Neurosci. 33 (2013) 17587–17596.
[26] L.L. Muldoon, J.I. Alvarez, D.J. Begley, R.J. Boado, G.J. Del Zoppo, N.D. Doolittle, B.
Engelhardt, J.M. Hallenbeck, R.R. Lonser, J.R. Ohlfest, A. Prat, M. Scarpa, R.J. Smeyne,
L.R. Drewes, E.A. Neuwelt, Immunologic privilege in the central nervous system
and the blood–brain barrier, J. Cereb. Blood FlowMetab. 33 (2013) 13–21.
[27] V.V. Bamm, G. Harauz, Hemoglobin as a source of iron overload inmultiple sclerosis:
does multiple sclerosis share risk factors with vascular disorders? Cell. Mol. Life Sci.
71 (2014) 1789–1798.
[28] V.V. Bamm, G. Harauz, Neurosci. Lett. 582 (2014) 130–132.
[29] V. Jeney, J. Balla, A. Yachie, Z. Varga, G.M. Vercellotti, J.W. Eaton, G. Balla, Pro-oxidant
and cytotoxic effects of circulating heme, Blood 100 (2002) 879–887.
[30] G. Silva, V. Jeney, A. Chora, R. Larsen, J. Balla, M.P. Soares, Oxidized hemoglobin is an
endogenous proinﬂammatory agonist that targets vascular endothelial cells, J. Biol.
Chem. 284 (2009) 29582–29595.
[31] V. Jeney, J.W. Eaton, G. Balla, J. Balla, Natural history of the bruise: formation,
elimination, and biological effects of oxidized hemoglobin, Oxidative Med. Cell.
Longev. 2013 (2013) 703571.
[32] L. Potor, E. Banyai, G. Becs, M.P. Soares, G. Balla, J. Balla, V. Jeney, Atherogenesis may
involve the prooxidant and proinﬂammatory effects of ferryl hemoglobin, Oxidative
Med. Cell. Longev. 2013 (2013) 676425.
[33] D. Keilin, E.F. Hartree, Reaction of methaemoglobin with hydrogen peroxide, Nature
166 (1950) 513–514.
[34] J. Balla, H.S. Jacob, G. Balla, K. Nath, J.W. Eaton, G.M. Vercellotti, Endothelial-cell
heme uptake from heme proteins: induction of sensitization and desensitization
to oxidant damage, Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 9285–9289.
[35] E. Nagy, J.W. Eaton, V. Jeney,M.P. Soares, Z. Varga, Z. Galajda, J. Szentmiklosi, G.Mehes,
T. Csonka, A. Smith, G.M. Vercellotti, G. Balla, J. Balla, Red cells, hemoglobin, heme, iron,
and atherogenesis, Arterioscler. Thromb. Vasc. Biol. 30 (2010) 1347–1353.
[36] J.E. Repine, R.B. Fox, E.M. Berger, Hydrogen peroxide kills Staphylococcus aureus by
reacting with staphylococcal iron to form hydroxyl radical, J. Biol. Chem. 256
(1981) 7094–7096.
[37] C.E. Lumsden, The immunogenesis of the multiple sclerosis plaque, Brain Res. 28
(1971) 365–390.
[38] Y. Karmon,M. Ramanathan,A.Minagar, R. Zivadinov, B.Weinstock-Guttman,Arterial, ve-
nous andother vascular risk factors inmultiple sclerosis, Neurol. Res. 34 (2012) 754–760.
[39] E. Conte, F.M. Megli, H. Khandelia, G. Jeschke, E. Bordignon, Lipid peroxidation and
water penetration in lipid bilayers: a W-band EPR study, Biochim. Biophys. Acta
1828 (2013) 510–517.
103V.V. Bamm et al. / Biochimica et Biophysica Acta 1852 (2015) 92–103[40] S. Ljubisavljevic, I. Stojanovic, D. Pavlovic, M. Milojkovic, D. Sokolovic, I. Stevanovic,
A. Petrovic, Suppression of the lipid peroxidation process in the CNS reduces
neurological expression of experimentally induced autoimmune encephalomyelitis,
Folia Neuropathol. 51 (2013) 51–57.
[41] G. Ferretti, T. Bacchetti, Peroxidation of lipoproteins in multiple sclerosis, J. Neurol.
Sci. 311 (2011) 92–97.
[42] G. Harauz, J.M. Boggs, Myelin management by the 18.5-kDa and 21.5-kDa classic
myelin basic protein isoforms, J. Neurochem. 125 (2013) 334–361.
[43] N.K. Cygan, J.C. Scheinost, T.D. Butters, P. Wentworth Jr., Adduction of cholesterol
5,6-secosterol aldehyde to membrane-bound myelin basic protein exposes an
immunodominant epitope, Biochemistry 50 (2011) 2092–2100.
[44] A.V. Bacheva, A.A. Belogurov, E.S. Kuzina, M.V. Serebriakova, N.A. Ponomarenko, V.D.
Knorre, V.M. Govorun, A.G. Gabibov, Functional degradation of myelin basic protein.
Proteomic approach, Bioorg. Khim. 37 (2011) 45–54.
[45] A.A. Musse, J.M. Boggs, G. Harauz, Deimination of membrane-bound myelin basic
protein in multiple sclerosis exposes an immunodominant epitope, Proc. Natl.
Acad. Sci. 103 (2006) 4422–4427.
[46] A.A. Musse, G. Harauz, Molecular “negativity” may underlie multiple sclerosis: role
of the myelin basic protein family in the pathogenesis of MS, Int. Rev. Neurobiol.
79 (2007) 149–172.
[47] J. Everse, N. Hsia, The toxicities of native and modiﬁed hemoglobins, Free Radic. Biol.
Med. 22 (1997) 1075–1099.
[48] E. Schroder, P. Eaton, Hydrogen peroxide as an endogenousmediator and exogenous
tool in cardiovascular research: issues and considerations, Curr. Opin. Pharmacol. 8
(2008) 153–159.
[49] P. Hahl, T. Davis, C. Washburn, J.T. Rogers, A. Smith, Mechanisms of neuroprotection
by hemopexin: modeling the control of heme and iron homeostasis in brain
neurons in inﬂammatory states, J. Neurochem. 125 (2013) 89–101.
[50] G.S.T. Smith, L. Chen, V.V. Bamm, J. Dutcher, G. Harauz, The interaction of zinc
with membrane-associated 18.5 kDa myelin basic protein: an attenuated total
reﬂectance-Fourier transform infrared spectroscopic study, Amino Acids 39
(3) (2010) 739–750.
[51] N. Grinshtein, V.V. Bamm, V.A. Tsemakhovich, N. Shaklai, Mechanism of low-
density lipoprotein oxidation by hemoglobin-derived iron, Biochemistry 42
(2003) 6977–6985.
[52] E. Antonini, M. Brunori joint author, Hemoglobin and myoglobin in their reactions
with ligands [By] Eraldo Antonini and Maurizio Brunori, North-Holland Pub. Co,
Amsterdam, 19uu.
[53] H.B. Dixon, R. McIntosh, Reduction of methaemoglobin in haemoglobin samples
using gel ﬁltration for continuous removal of reaction products, Nature 213
(1967) 399–400.
[54] H. Inouye, D.A. Kirschner, Membrane interactions in nerve myelin: II. Determination
of surface charge from biochemical data, Biophys. J. 53 (0418) 247–260.
[55] G. Bartlett, Phosphorus assay in column chromatography, J. Biol. Chem. 234 (1959)
466–468.
[56] L.M. Foster, T. Phan, A.N. Verity, D. Bredesen, A.T. Campagnoni, Generation and
analysis of normal and shiverer temperature-sensitive immortalized cell lines
exhibiting phenotypic characteristics of oligodendrocytes at several stages of
differentiation, Dev. Neurosci. 15 (1993) 100–109.
[57] A.N. Verity, D. Bredesen, C. Vonderscher, V.W. Handley, A.T. Campagnoni, Expression
of myelin protein genes and other myelin components in an oligodendrocytic cell
line conditionally immortalized with a temperature-sensitive retrovirus, J.
Neurochem. 60 (1993) 577–587.
[58] G.S. Smith, L. Homchaudhuri, J.M. Boggs, G. Harauz, Classic 18.5- and 21.5-kDa
myelin basic protein isoforms associate with cytoskeletal and SH3-domain proteins
in the immortalized N19-oligodendroglial cell line stimulated by phorbol ester and
IGF-1, Neurochem. Res. 37 (2012) 1277–1295.
[59] U.K. Laemmli, Cleavage of structural proteins during the assembly of bacteriophage
T4, Nature 227 (1970) 680–685.
[60] H. Schägger, G. von Jagow, Tricine–sodium dodecyl sulfate-polyacrylamide gel
electrophoresis for the separation of proteins in the range from 1 to 100 kDa,
Anal. Biochem. 166 (1987) 368–379.
[61] Y.I. Miller, S.M. Altamentova, N. Shaklai, Oxidation of low-density lipoprotein by
hemoglobin stems from a heme-initiated globin radical: antioxidant role of
haptoglobin, Biochemistry 36 (1997) 12189–12198.
[62] V.V. Bamm, V.A. Tsemakhovich, N. Shaklai, Oxidation of low-density lipoprotein by
hemoglobin–hemichrome, Int. J. Biochem. Cell Biol. 35 (2003) 349–358.
[63] P. Kaplan, M. Doval, Z. Majerova, J. Lehotsky, P. Racay, Iron-induced lipid peroxida-
tion and protein modiﬁcation in endoplasmic reticulum membranes. Protection by
stobadine, Int. J. Biochem. Cell Biol. 32 (2000) 539–547.
[64] J.A. Buege, S.D. Aust, Microsomal lipid peroxidation, Methods Enzymol. 52 (1978)
302–310.
[65] H. Shimasaki, N. Hirai, N. Ueta, Comparison of ﬂuorescence characteristics of
products of peroxidation of membrane phospholipids with those of products
derived from reaction of malonaldehyde with glycine as a model of lipofuscin
ﬂuorescent substances, J. Biochem. 104 (1988) 761–766.
[66] C.C.Winterbourn, Oxidative reactions of hemoglobin, Methods Enzymol. 186 (1990)
265–272.
[67] J.A. Berzofsky, J. Peisach, W.E. Blumberg, Sulfheme proteins. I. Optical and magnetic
properties of sulfmyoglobin and its derivatives, J. Biol. Chem. 246 (1971) 3367–3377.
[68] K.D.Whitburn, J.J. Shieh, R.M. Sellers, M.Z. Hoffman, I.A. Taub, Redox transformations
in ferrimyoglobin induced by radiation-generated free radicals in aqueous solution, J.
Biol. Chem. 257 (1982) 1860–1869.
[69] P. Pajot, O. Groudinsky, Molecular weight and quaternary structure of yeast L-lactate
dehydrogenase (cytochrome b2). 2. Revised heme extinction coefﬁcients and
minimal molecular weight, Eur. J. Biochem. 12 (1970) 158–164.[70] C. Giulivi, K.J. Davies, Hydrogen peroxide-mediated ferrylhemoglobin generation
in vitro and in red blood cells, Methods Enzymol. 231 (1994) 490–496.
[71] F.W. TEALE, Haem-globin equilibrium studies by ﬂuorimetry, Biochim. Biophys. Acta
35 (1959) 289–291.
[72] N. Alloisio, D. Michelon, E. Bannier, A. Revol, Y. Beuzard, J. Delaunay, Alterations
of red cell membrane proteins and hemoglobin under natural and experimental
oxidant stress, Biochim. Biophys. Acta 691 (1982) 300–308.
[73] L. Zhong, V.V. Bamm, M.A. Ahmed, G. Harauz, V. Ladizhansky, Solid-state NMR
spectroscopy of 18.5 kDa myelin basic protein reconstituted with lipid vesicles:
spectroscopic characterisation and spectral assignments of solvent-exposed protein
fragments, Biochim. Biophys. Acta Biomembr. 1768 (2007) 3193–3205.
[74] E.M. Haacke, M. Makki, Y. Ge, M. Maheshwari, V. Sehgal, J. Hu, M. Selvan, Z. Wu, Z.
Latif, Y. Xuan, O. Khan, J. Garbern, R.I. Grossman, Characterizing iron deposition in
multiple sclerosis lesions using susceptibility weighted imaging, J. Magn. Reson.
Imaging 29 (2009) 537–544.
[75] J. Hagemeier, M. Heininen-Brown, G.U. Poloni, N. Bergsland, C.R. Magnano, J. Durfee,
C. Kennedy, E. Carl, B. Weinstock-Guttman, M.G. Dwyer, R. Zivadinov, Iron depo-
sition inmultiple sclerosis lesions measured by susceptibility-weighted imaging
ﬁltered phase: a case control study, J. Magn. Reson. Imaging 36 (2012) 73–83.
[76] J. Hagemeier, E.A. Yeh, M.H. Brown, N. Bergsland, M.G. Dwyer, E. Carl, B.
Weinstock-Guttman, R. Zivadinov, Iron content of the pulvinar nucleus of the thalamus
is increased in adolescent multiple sclerosis, Mult. Scler. 19 (2013) 567–576.
[77] A.M. Al-Radaideh, S.J. Wharton, S.Y. Lim, C.R. Tench, P.S. Morgan, R.W. Bowtell, C.S.
Constantinescu, P.A. Gowland, Increased iron accumulation occurs in the earliest
stages of demyelinating disease: an ultra-high ﬁeld susceptibility mapping study
in Clinically Isolated Syndrome, Mult. Scler. 19 (2013) 896–903.
[78] N. Nathoo, S. Agrawal, Y. Wu, S. Haylock-Jacobs, V.W. Yong, T. Foniok, S. Barnes, A.
Obenaus, J.F. Dunn, Susceptibility-weighted imaging in the experimental autoimmune
encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin,
iron deposition and demyelination, Mult. Scler. 19 (2013) 721–731.
[79] R. Williams, A.M. Rohr, W.T. Wang, I.Y. Choi, P. Lee, N.E. Berman, S.G. Lynch, S.M.
LeVine, Iron deposition is independent of cellular inﬂammation in a cerebral
model of multiple sclerosis, BMC Neurosci. 12 (2011) (59-2202-12-59).
[80] S.A. Sands, R. Williams, S. Marshall 3rd, S.M. LeVine, Perivascular iron deposits
are associated with protein nitration in cerebral experimental autoimmune
encephalomyelitis, Neurosci. Lett. 582 (2014) 133–138.
[81] R. Prohaska, O.C. Sibon, D.D. Rudnicki, A. Danek, S.J. Hayﬂick, E.M. Verhaag, J.J. Vonk,
R.L. Margolis, R.H. Walker, Brain, blood, and iron: perspectives on the roles of
erythrocytes and iron in neurodegeneration, Neurobiol. Dis. 46 (2012) 607–624.
[82] F. Vallelian, T. Pimenova, C.P. Pereira, B. Abraham, M.G. Mikolajczyk, G. Schoedon, R.
Zenobi, A.I. Alayash, P.W. Buehler, D.J. Schaer, The reaction of hydrogen peroxide
with hemoglobin induces extensive alpha-globin crosslinking and impairs the
interaction of hemoglobin with endogenous scavenger pathways, Free Radic. Biol.
Med. 45 (2008) 1150–1158.
[83] C.C. Winterbourn, Free-radical production and oxidative reactions of hemoglobin,
Environ. Health Perspect. 64 (1985) 321–330.
[84] C. Giulivi, K.J. Davies, A novel antioxidant role for hemoglobin. The comproportionation
of ferrylhemoglobin with oxyhemoglobin, J. Biol. Chem. 265 (1990) 19453–19460.
[85] L.L. McLeod, A.I. Alayash, Detection of a ferrylhemoglobin intermediate in an
endothelial cell model after hypoxia–reoxygenation, Am. J. Physiol. 277 (1999)
H92–H99.
[86] K.M. McArthur, M.J. Davies, Detection and reactions of the globin radical in
haemoglobin, Biochim. Biophys. Acta 1202 (1993) 173–181.
[87] N.V. Gorbunov, A.N. Osipov, B.W. Day, B. Zayas-Rivera, V.E. Kagan, N.M. Elsayed,
Reduction of ferrylmyoglobin and ferrylhemoglobin by nitric oxide: a protective
mechanism against ferryl hemoprotein-induced oxidations, Biochemistry 34
(1995) 6689–6699.
[88] F.A. Lara, S.A. Kahn, A.C. da Fonseca, C.P. Bahia, J.P. Pinho, A.V. Graca-Souza, J.C.
Houzel, P.L. de Oliveira, V. Moura-Neto, M.F. Oliveira, On the fate of extracellular
hemoglobin and heme in brain, J. Cereb. Blood Flow Metab. 29 (2009) 1109–1120.
[89] G. Balla, G.M. Vercellotti, U. Muller-Eberhard, J. Eaton, H.S. Jacob, Exposure of
endothelial cells to free heme potentiates damage mediated by granulocytes
and toxic oxygen species, Lab. Invest. 64 (1991) 648–655.
[90] G. Balla, H.S. Jacob, J.W. Eaton, J.D. Belcher, G.M. Vercellotti, Hemin: a possible
physiological mediator of low density lipoprotein oxidation and endothelial
injury, Arterioscler. Thromb. 11 (1991) 1700–1711.
[91] J. Balla, H.S. Jacob, G. Balla, K. Nath, G.M. Vercellotti, Endothelial cell heme oxygenase
and ferritin induction by heme proteins: a possible mechanism limiting shock
damage, Trans. Assoc. Am. Phys. 105 (1992) 1–6.
[92] C. Rice-Evans, R. Burdon, Free radical–lipid interactions and their pathological
consequences, Prog. Lipid Res. 32 (1993) 71–110.
[93] V.V. Bamm, V.A. Tsemakhovich, M. Shaklai, N. Shaklai, Haptoglobin phenotypes
differ in their ability to inhibit heme transfer from hemoglobin to LDL, Biochemistry
43 (2004) 3899–3906.
[94] E. Profumo, B. Buttari, R. Rigano, Oxidative stress in cardiovascular inﬂammation:
its involvement in autoimmune responses, Int. J. Inﬂamm. 2011 (2011) 295705.
[95] S. Samson, L. Mundkur, V.V. Kakkar, Immune response to lipoproteins in
atherosclerosis, Cholesterol 2012 (2012) 571846.
[96] M.C. McGahan, A.M. Grimes, L.N. Fleisher, Hemoglobin exacerbates the ocular
inﬂammatory response to endotoxin, Graefes Arch. Clin. Exp. Ophthalmol. 234
(1996) 643–647.
[97] R.T. Figueiredo, P.L. Fernandez, D.S. Mourao-Sa, B.N. Porto, F.F. Dutra, L.S. Alves, M.F.
Oliveira, P.L. Oliveira, A.V. Graca-Souza, M.T. Bozza, Characterization of heme as
activator of Toll-like receptor 4, J. Biol. Chem. 282 (2007) 20221–20229.
[98] C.F. Christiansen, Risk of vascular disease in patients with multiple sclerosis:
a review, Neurol. Res. 34 (2012) 746–753.
